Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double‐blind placebo‐controlled trial

Background:  Probiotic bacteria are suggested to reduce symptoms of the atopic eczema/dermatitis syndrome (AEDS) in food‐allergic infants. We aimed to investigate whether probiotic bacteria have any beneficial effect on AEDS.

[1]  J. Bousquet,et al.  Microbial products in allergy prevention and therapy , 2003, Allergy.

[2]  K. Michaelsen,et al.  Effect of probiotic Lactobacillus strains in children with atopic dermatitis. , 2003, The Journal of allergy and clinical immunology.

[3]  G. Pershagen,et al.  An anthroposophic lifestyle and intestinal microflora in infancy , 2002, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[4]  M. Di Gioacchino,et al.  Probiotics and food‐allergic diseases , 2002, Allergy.

[5]  T. Haahtela,et al.  No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch‐pollen allergy: a placebo‐controlled double‐blind study , 2002, Allergy.

[6]  M. Jünger,et al.  Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. , 2002, The Journal of allergy and clinical immunology.

[7]  R. Reading.  Probiotics in primary prevention of atopic disease: a randomised placebo‐controlled trial. , 2001 .

[8]  K. Julge,et al.  Allergy development and the intestinal microflora during the first year of life. , 2001, The Journal of allergy and clinical immunology.

[9]  J. Bousquet,et al.  A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task force , 2001, Allergy.

[10]  S. Salminen,et al.  Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial , 2001, The Lancet.

[11]  B. Niggemann,et al.  Prospective, controlled, multi‐center study on the effect of an amino‐acid‐based formula in infants with cow's milk allergy/intolerance and atopic dermatitis , 2001, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[12]  E. Isolauri,et al.  Interleukin‐10 generation in atopic children following oral Lactobacillus rhamnosus GG , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[13]  S. Salminen,et al.  Probiotics in the management of atopic eczema , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  P. Brigidi,et al.  Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. , 2000, Gastroenterology.

[15]  S. Bonini,et al.  Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study , 2000, BMJ : British Medical Journal.

[16]  H. Sampson,et al.  Food hypersensitivity and atopic dermatitis: pathophysiology, epidemiology, diagnosis, and management. , 1999, The Journal of allergy and clinical immunology.

[17]  S. Salminen,et al.  New aspects of probiotics – a novel approach in the management of food allergy , 1999, Allergy.

[18]  A. Muraro,et al.  Dietary products used in infants for treatment and prevention of food allergy. , 1999, Archives of disease in childhood.

[19]  Wold,et al.  Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL‐12 production , 1999, Clinical and experimental immunology.

[20]  P. Naaber,et al.  The intestinal microflora in allergic Estonian and Swedish 2‐year‐old children , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[21]  T. Mitsuoka,et al.  Effect of bifidobacteria feeding on fecal flora and production of immunoglobulins in lactating mouse. , 1999, International journal of food microbiology.

[22]  M. Kurimoto,et al.  Lactobacilli and Streptococci Induce Interleukin-12 (IL-12), IL-18, and Gamma Interferon Production in Human Peripheral Blood Mononuclear Cells , 1998, Infection and Immunity.

[23]  E. Isolauri,et al.  Probiotics: a novel approach in the management of food allergy. , 1997, The Journal of allergy and clinical immunology.

[24]  K. Kalimo,et al.  Life‐threatening, recurrent anaphylaxis caused by allergy to gliadin and exercise , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[25]  F. M. Rombouts,et al.  Raffinose-Bifidobacterium (RB) agar, a new selective medium for bifidobacteria. , 1996 .

[26]  K. Turjanmaa,et al.  Efficacy and safety of hydrolyzed cow milk and amino acid-derived formulas in infants with cow milk allergy. , 1995, The Journal of pediatrics.

[27]  G. Guillet,et al.  Natural history of sensitizations in atopic dermatitis. A 3-year follow-up in 250 children: food allergy and high risk of respiratory symptoms. , 1992, Archives of dermatology.

[28]  R. Fuller,et al.  Probiotics in human medicine. , 1991, Gut.

[29]  G. Canonica,et al.  Antiallergic drugs and the immune response , 1989, Allergy.

[30]  M. Mayer,et al.  Revised nomenclature. , 1980, Journal of immunology.

[31]  S. Salminen,et al.  Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. , 2001, The Journal of allergy and clinical immunology.

[32]  T. Suomalainen,et al.  Propionic acid bacteria as protective cultures in fermented milks and breads , 1999 .

[33]  Julia Brasch,et al.  Severity Scoring of Atopic Dermatitis: The SCORAD Index , 1993 .

[34]  A. Taïeb,et al.  Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. , 1993, Dermatology.

[35]  J. Bousquet,et al.  Skin tests used in type I allergy testing Position paper. Sub-Committee on Skin Tests of the European Academy of Allergology and Clinical Immunology. , 1989, Allergy.